Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion.

Stem Cell Res

Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. Electronic address:

Published: October 2024

We generated two human induced pluripotent cell (hiPSC) isogenic clones from an 11-year-old patient with 6q27 deletion syndrome. The heterozygous deletion encompasses approximately 240 kilobases, affecting 6 genes (promoter region of WDR27, coding regions of C6orf120, PHF10, DYNLT2, ERMARD, LINC00242). The patient suffered from epilepsy, psychosocial retardation, and a metabolic disorder. The patient also had a history of SHH-medulloblastoma as an infant. The generated hiPSCs represent a useful tool for modelling 6q27 deletion syndrome in vitro and understanding the molecular basis of the disorder.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2024.103524DOI Listing

Publication Analysis

Top Keywords

6q27 deletion
12
deletion syndrome
8
generation isogenic
4
isogenic patient-derived
4
patient-derived human-induced
4
human-induced pluripotent
4
pluripotent stem
4
stem cell
4
cell clones
4
clones 6q27
4

Similar Publications

Contribution of copy number variations to education, socioeconomic status and cognition from a genome-wide study of 305,401 subjects.

Mol Psychiatry

August 2024

Department of Neurology and National Center for Neurological Disorders, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.

Educational attainment (EA), socioeconomic status (SES) and cognition are phenotypically and genetically linked to health outcomes. However, the role of copy number variations (CNVs) in influencing EA/SES/cognition remains unclear. Using a large-scale (n = 305,401) genome-wide CNV-level association analysis, we discovered 33 CNV loci significantly associated with EA/SES/cognition, 20 of which were novel (deletions at 2p22.

View Article and Find Full Text PDF

Genomic profiles and clinical presentation of chordoma.

Acta Neuropathol Commun

August 2024

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Article Synopsis
  • Chordoma is a rare bone cancer affecting mainly adults, with an average diagnosis age of 45.5 years; it is most commonly found in the clivus, spinal column, and sacrum.
  • A large majority of patients (97.5%) underwent surgery, and many also received supplementary treatments; however, no significant cancer types appeared frequently among patients' families aside from the most common cancers.
  • Genomic analysis of tumor samples revealed recurrent mutations, notably in PIK3CA, and differences in genetic alterations based on the tumor location, indicating a complex relationship between tumor genetics and clinical outcomes.
View Article and Find Full Text PDF

Generation of two isogenic patient-derived human-induced pluripotent stem cell clones with 6q27 deletion.

Stem Cell Res

October 2024

Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. Electronic address:

We generated two human induced pluripotent cell (hiPSC) isogenic clones from an 11-year-old patient with 6q27 deletion syndrome. The heterozygous deletion encompasses approximately 240 kilobases, affecting 6 genes (promoter region of WDR27, coding regions of C6orf120, PHF10, DYNLT2, ERMARD, LINC00242). The patient suffered from epilepsy, psychosocial retardation, and a metabolic disorder.

View Article and Find Full Text PDF

Obesity is known as a heterogeneous and multifactorial disease. The distribution of body fat is crucial for the development of metabolic complications. Comprehensive genetic analyses on different fat tissues are rare but necessary to provide more detailed information.

View Article and Find Full Text PDF

[Multiomics and Multidimensional Testing for Efficacy Monitoring of Patients with Lymphoma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

June 2023

Department of Oncology, The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052, Henan Province, China, Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou 450052, Henan Province, China,E-mail:

Objective: To explore the role of a new blood-based, multiomics and multidimensional method for evaluating the efficacy of patients with lymphoma.

Methods: 10 ml peripheral blood was extracted from each patient, and the genomic copy number aberrations (CNA) and fragment size (FS) were evaluated by low-depth whole genome sequencing of cfDNA, and the level of a group of plasma tumor marker (PTM) were detected at the same time. The cancer efficacy score (CES) was obtained by standardized transformation of the value of above three numerical indexes, and the changes of CES before and after treatment were compared to evaluate the patient's response to the treatment regimen.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!